Gaia Tabacco
Overview
Explore the profile of Gaia Tabacco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naciu A, Nusca A, Palermo A, Piccirillo F, Tabacco G, DAmico A, et al.
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40037625
Context: Both primary hyperparathyroidism (PHPT) and chronic hypoparathyroidism (HypoPT) are associated with the onset and development of cardiovascular diseases (CVDs). However, the molecular mechanisms underlying the effects of parathyroid disorders...
2.
Palermo A, Naciu A, Donovan Y, Tabacco G, Zavatta G
Curr Osteoporos Rep
. 2025 Feb;
23(1):12.
PMID: 39987371
Purpose Of Review: to describe and compare the efficacy and safety of the main PTH treatments, namely PTH(1-84) and palopegteriparatide, for the management of hypoparathyroidism. Recent Findings: neither PTH (1-84)...
3.
4.
Longo F, Sarubbi A, Palladino C, Palermo A, Naciu A, Crescenzi A, et al.
Medicina (Kaunas)
. 2025 Jan;
60(12.
PMID: 39768933
Parathyroid carcinoma (PC) is a rare endocrine malignancy that poses significant diagnostic challenges due to its resemblance to benign conditions. This case series describes the clinical presentation, diagnosis, management, and...
5.
Yeh R, Kuo J, Huang B, Shobeiri P, Lee J, Tay Y, et al.
Eur Radiol
. 2024 Oct;
35(3):1325-1336.
PMID: 39476058
Purpose: To train and validate machine learning-derived clinical decision algorithm (CDA) for the diagnosis of hyperfunctioning parathyroid glands using preoperative variables to facilitate surgical planning. Methods: This retrospective study included...
6.
Palermo A, Tabacco G, Makras P, Zavatta G, Trimboli P, Castellano E, et al.
Rev Endocr Metab Disord
. 2024 Aug;
25(5):875-896.
PMID: 39162944
Primary hyperparathyroidism (PHPT) is a common endocrine disease characterized by hypercalcemia due to inappropriately high parathyroid hormone secretion. While in the typical, symptomatic form of the disease diagnosis is set...
7.
Birtolo M, Pedersini R, Palermo A, Vena W, Morenghi E, Cristofolini G, et al.
Eur J Endocrinol
. 2024 Jul;
191(2):117-125.
PMID: 39056237
Background: Bone health management in premenopausal women with breast cancer (BC) under hormone-deprivation therapies (HDTs) is often challenging, and the effectiveness of bone-active drugs is still unknown. Methods: This retrospective...
8.
Anastasilakis A, Yavropoulou M, Palermo A, Makras P, Paccou J, Tabacco G, et al.
Eur J Endocrinol
. 2024 Jun;
191(1):R9-R21.
PMID: 38938063
Osteoanabolic agents are used as a first line treatment in patients at high fracture risk. The PTH receptor 1 (PTH1R) agonists teriparatide (TPTD) and abaloparatide (ABL) increase bone formation, bone...
9.
Pozzilli V, Toro S, Tabacco G, Naciu A, Palermo A, Di Lazzaro V, et al.
Neurol Sci
. 2024 Feb;
45(8):4101.
PMID: 38369584
No abstract available.
10.
Pozzilli V, Toro S, Tabacco G, Naciu A, Palermo A, Di Lazzaro V, et al.
Neurol Sci
. 2024 Jan;
45(5):2325-2329.
PMID: 38285328
Introduction: Restless leg syndrome (RLS) is an invalidating neurological disorder with a complex, largely unknown pathophysiology. While RLS is observed in Parkinson's disease and in renal failure, idiopathic cases are...